Technological watch

Element launches rapid response pharmaceutical testing service

Element has launched its Rapid Response Pharmaceutical Testing Service from its Manchester Life Sciences laboratory.

× Element

This offering will support the pharmaceutical industry by providing testing solutions for customers worldwide to meet the demands of today's market.

In response to the growing need for timely and reliable testing services in the pharmaceutical sector, Element has developed a facility that streamlines the testing process without compromising accuracy or quality. Leveraging advanced technologies and industry expertise, Element's Rapid Response Pharmaceutical Testing Service delivers results with unprecedented speed and efficiency.

The service covers a range of testing requirements, including but not limited to:

  • Active pharmaceutical ingredients (API) & final drug products
  • Delivery devices & packaging
  • Biopharmaceutical single-use systems (SUS)
  • Extractables and leachables
  • Degradation production
  • Production process-related impurities
  • Residual solvents USP
  • Extrinsic contamination
  • Elemental impurities – ICH Q3D
The service will aid customers by quickly reacting to and resolving problems arising during the pharmaceutical and medical device development processes. It will support resolving complex issues and requirements linked to regulatory submissions. With a commitment to excellence and customer satisfaction, Element guarantees accurate and reliable results delivered in record time.

"Our Rapid Response Pharmaceutical Testing Service represents a significant advancement for Element in supporting pharmaceutical and Medical Device testing and Development," said Iain Gibb, general manager at Element’s Manchester, UK lab. "We understand the critical importance of timely and precise testing in the pharmaceutical industry, and our new service is designed to address these needs head-on. Whether our customers require routine testing or urgent analysis, they can trust Element to deliver exceptional results with unmatched speed and efficiency."

Back to Search Results Tags Element Pharma Testing Top Stories

Publication date: 25/03/2024

Medical Plastics News


This project has received funding from the Bio Based Industries Joint Undertaking under the European Union’s Horizon 2020 research and innovation programme under grant agreement No 837761.